Is HTBX or JNJ a better dividend investment in 2026?

HTBX currently yields 84.03% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: HTBX offers higher current income.

What is the dividend yield difference between HTBX and JNJ?

HTBX has a forward dividend yield of 84.03% ($2.00/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 80.67 percentage points.

Home › Compare › HTBX vs JNJ

HTBX vs JNJ: Dividend Comparison 2026

HTBX yields 84.03% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 HTBX wins by $1.96M in total portfolio value

INVESTMENT

TIME HORIZON10 years

HTBX

● Live price

84.03%

Share price

$2.38

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$1.98M

Annual income

$593,470.68

Full HTBX calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — HTBX vs JNJ

📍 HTBX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	HTBX	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, HTBX + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

HTBX pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HTBX

Annual income on $10K today (after 15% tax)

$7,142.86/yr

After 10yr DRIP, annual income (after tax)

$504,450.08/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, HTBX beats the other by $503,746.47/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HTBX + JNJ for your $10,000?

HTBX: 50%JNJ: 50%

100% JNJ50/50100% HTBX

Portfolio after 10yr

$1.00M

Annual income

$297,149.23/yr

Blended yield

29.67%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

HTBX

Analyst Ratings

Buy

Consensus: Buy

Altman Z

-22.5

Piotroski

2/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HTBX buys

JNJ buys

No recent congressional trades found for HTBX or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricHTBXJNJ

Forward yield	84.03% ✓	3.36%
Annual dividend / share	$2.00	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$1.98M	$20.0K ✓
Annual income after 10y	$593,470.68 ✓	$827.78
Total dividends collected	$1.73M	$5.6K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare
Analyst consensus	Buy	Buy

Year-by-year: HTBX vs JNJ ($10,000, DRIP)

Year	HTBX Portfolio	HTBX Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$19,103	$8,403.36	$10,676	$355.77	+$8.4K → HTBX
2	$35,444	$15,003.03	$11,407	$389.39	+$24.0K → HTBX
3	$63,940	$26,014.99	$12,198	$426.53	+$51.7K → HTBX
4	$112,276	$43,860.35	$13,056	$467.62	+$99.2K → HTBX
5	$192,114	$71,978.72	$13,987	$513.12	+$178.1K → HTBX
6	$320,666	$115,104.62	$14,998	$563.56	+$305.7K → HTBX
7	$522,671	$179,557.63	$16,098	$619.52	+$506.6K → HTBX
8	$832,781	$273,523.56	$17,295	$681.69	+$815.5K → HTBX
9	$1,298,375	$407,299.36	$18,599	$750.82	+$1.28M → HTBX
10	$1,982,732	$593,470.68	$20,022	$827.78	+$1.96M → HTBX

HTBX vs JNJ: Complete Analysis 2026

HTBX — Stock

Heat Biologics, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating platform that functions as an immune activator to stimulate and expand T-cells; and ComPACT, which delivers antigen driven T-cell activation and specific co-stimulation in a single product. The company develops HS-110, which has completed enrollment in a Phase II clinical trial to treat patients with advanced non-small cell lung cancer; and HS-130 that is in Phase I clinical trial for the treatment of advanced solid tumors. Its products also include PTX-35, a novel T-cell co-stimulator agonist antibody targeting DR3/TNFRSF25 that is in Phase I clinical trial; DR3/TNFRSF25 for various immunotherapy approaches; and COVID-19 vaccine, which is in preclinical stage. Heat Biologics, Inc. has a collaboration with Dr. James Shapiro at University of Alberta to manufacture surrogate mouse version of PTX-35. The company was incorporated in 2008 and is headquartered in Morrisville, North Carolina.

Full HTBX Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this HTBX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HTBX vs SCHD HTBX vs JEPI HTBX vs O HTBX vs KO HTBX vs MAIN HTBX vs ABBV HTBX vs MRK HTBX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.